{
    "medicine_id": "c65bb6bab3a1c0edf0e142833619e6a5d09857e5",
    "platform_id": "DB09498",
    "metadata": {
        "name": "Metastron 1 mCi 1mL Injection powder lyophilized for solution",
        "composition": "1 mCi 1mL Strontium chloride Sr 89",
        "clinical_particulars": {
            "therapeutic_indications": "Strontium 89 Chloride Injection is indicated as a paliative for the relief of bone pain in patients with skeletal metastases It is impotant to confirm the presence of bone metastases prior the beginning of therapy A31264",
            "contraindications": {
                "disease": "A single case of fatal septicemia following leukopenia has been reported during clinical trials Bone marrow depression leading to thrombocytopenia unusual bleeding or bruising black tarry stools blood in urine or stools pinpoint red spots on skin and leukopenia cough or hoarseness fever or chills lower back or side pain painful or difficult urination",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Metastatic bone lesions are zones of high bone mineral turnover Thus there is a constant need of calcium supply for the development of the malignancy Strontium chloride 89 is a divalent ion similar to calcium therefore it is taken up by sites of active osteogenesis This relieves bone metastatic driven pain withouth generating important side effects and it also presents a very little radioprotection concern A31265 Once combined with external beam radiotherapy strontium chloride 89 can emit \u03b2 particules with a maximum range in tissue of 6 8mm This radiation is capable to reduce new bone metastases and produces an analgesic role A31266",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}